Validation of the modified fatigue impact scale in Danish patients with systemic lupus erythematosus

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review


Background: Patients with systemic lupus erythematosus (SLE) experience significant fatigue, a debilitating symptom associated with reduced quality of life. A simple, reliable multidimensional method for assessing fatigue has not yet been validated for Danish patients with SLE.Objectives: The primary objective was to study the internal consistency, test-retest reliability, and construct validity (convergent and discriminant validity) of the multidimensional Modified Fatigue Impact Scale (MFIS) in patients with SLE. The secondary objective was to investigate the contribution of disease activity and organ damage to fatigue.Methods: Data from the textquotedblrightBio and Genome Bank Study in Centre for SLE and Vasculitistextquotedblright obtained through routine visits were used. Fatigue was assessed using the MFIS and Short Form 36 (SF36). Internal consistency of the MFIS was assessed with Cronbach’s alpha (α). Test-retest reliability was evaluated using the intraclass correlation coefficient (ICC). Construct validity was studied using Spearman’s rank correlation coefficient (rs) and Principal Component Analysis (PCA) between MFIS and SF36 vitality (VT-SF36) and mental health (MH-SF36) subscales. Association between MFIS and disease activity and organ damage was estimated with Spearman’s rank correlation coefficient.Results: The study included 30 patients with SLE. Internal consistency of the MFIS was excellent with Cronbach’s α = 0.97 for the complete scale. Excellent test-retest reliability was found with ICC = 0.95 (95 0.88-0.98, p lt; 0.05). Construct validity was confirmed by Spearman’s correlation (VT-SF36: rs = -0.73, p lt; 0.001 (Fig. 1). MH-SF36: rs = -0.74, p lt; 0.001 (Fig. 2)) and PCA with explained variance from the first two principal components (PC) (VT-SF36: PC1 = 60.2 PC2 = 8.5SF36: PC1 = 58.5 PC2 = 7.4. No significant correlation was found between the MFIS and SLEDAI (rs = 0.04, p = 0.84) or SLICC Damage Index (rs = 0.32, p = 0.08).Figure 1. Scatter plot of the Modified Fatigue Impact Scale (MFIS) and the Short Form 36 vitality (VT-SF36) subscale.Figure 2. Scatter plot of the Modified Fatigue Impact Scale (MFIS) and the Short Form 36 mental health (MH-SF36) subscale.Conclusion: The present study found the multidimensional assessment of fatigue with MFIS to be a reliable and valid instrument in SLE. The MFIS might provide more detailed information about fatigue in future studies. In agreement with some previous studies we found no association between fatigue and SLEDAI or SLICC which raises questions about the cause of this symptom. Further and larger studies are needed to investigate if any association between fatigue and disease components exist.Disclosure of Interests: None declared
TidsskriftAnnals of the Rheumatic Diseases
Udgave nummerSuppl. 1
Sider (fra-til)895-896
Antal sider2
StatusUdgivet - 3 jun. 2020
BegivenhedAnnual European Congress of Rheumatology: EULAR 2020 (e-congress, online) - E-congress, online
Varighed: 3 jun. 20203 jun. 2020


KonferenceAnnual European Congress of Rheumatology: EULAR 2020 (e-congress, online)
LokationE-congress, online